Menopause Flashcards

1
Q

Definition of menopause

A

The final menstrual period, can only be diagnosed after 12 consecutive months of amenorrhoea while not on any hormonal treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Definition of perimenopause

A

The symptoms experienced in the years preceding menopause while ovarian activity fluctuates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Definition of surgical menopause

A

Menopause occurring when functional ovaries are surgically removed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Definition of premature menopause

A

Menopause occurring before the age of 45

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Average age of menopause in Western society

A

52 years (no change in last 150 years)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Iatrogenic causes of menopause

A

Surgical removal of functioning ovaries
Radiotherapy
Chemotherapy
Temporarily during GnRH analogue treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Causes of primary premature ovarian failure

A
Chromosome abnormalities (Turner's, Fragile X)
Autoimmune: hypothyroidism, Addison's, Myasthenia Gravis
Enzyme: galactosaemia, 17a-hydroxylase deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Causes of secondary premature ovarian failure

A

Surgical menopause
Chemo or radiotherapy
Infectiosn (TB, mumps, malaria, varicella)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Endocrine changes in menopause

A

First change: fall in inhibin production (responsible for FSH production inhibition) - increased FSH

Reduces oestradiol levels- eventually insufficient to stimulate endometrial proliferation = menopause
Further decline in subsequent years - effects on all oestrogen-responsive tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GU effects of menopause

A

Vaginal atrophy - trauma, dryness, spontaneous bleeding, infection
Distal urethra + trigone bladder - similar atrophy - urinary symptoms without infection
Pelvic floor dysfunction - weakening of supporting ligaments and tissues - increased prolapse and stress incontinence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Osteoporosis mechanism in menopause

A

oestrogen = anti-resorptive agent on trabecular bone

Thus, dec. oestrogen - inc. bone resorption - dec. bone density

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Oestrogen effects on CVS

A

inc. LDL, dec. HDL
direct effect on vessel wall - vasodilation via NO
thus increased risk of CVD after menopause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Short-term symptoms of menopause (0-5y)

A

Vasomotor: hot flushes, night sweats
Psychological: labile mood, anxiety, tearfulness
Cognitive: loss of concentration, poor memory
Joint aches and pains
Dry, itchy skin
Hair changes
Reduced libido

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Intermediate effects of menopause (3-10 years)

A
vaginal dryness, soreness
Dyspareunia
Sensory urgency
Urinary frequency
Recurrent UTIs
Urogenital prolapse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Long term effects of menopause (over 10y)

A

Osteoporosis
Cardiovascular disease
Dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Assessment of menopause:

A

frequency, severity and types of symptoms and impact on daily life
for most women, menopausal symptoms are relatively short lived and will settle within a few years
use as opportunity to raise awareness and practice preventative medicine

17
Q

lifestyle management of menopause

A

Smoking cessation
Optimise diet
Regular, low-intensity exercise
Minimise weight gain (average weight gain of 1kg/year around menopause)

18
Q

Alternative/complementary management of menopause

A

little is known about efficacy or safety:
Acupuncture, reflexology, magnetism
Herbal (black cohosh, evening primrose oil, st john’s wort, ginseng, ginko bilboa)
Bio-identical hormones (DHEA, natural progesterone gel, phytoestrogens - isoflavones, red clover)

19
Q

Non-hormonal pharmaceutical management options for menopause

A

SSRIs and gabapentin:

  • reduce hot flushes in short term
  • significant side effect profile

Alpha-adrenergic agnoists (Clonidine)

  • reduces hot flushes
  • far less effective than HRT
20
Q

Hormones to be given in HRT for menopause

A

Oestrogen - can only be given alone if no uterus is remaining (otherwise risk of endometrial cancer) + progesterone if uterus present
testosterone if surgical/chemo induced menopause

21
Q

Time frame of HRT

A

Minimal effective dose for shortest duration
Ideally should be discontinued by 5 years
average woman will need symptomatic relief for 2-3 years

22
Q

Routes of oestrogen administration

A

Oral - oestrone released into circulation, less expensive
Transdermal: avoids first-pass effect, reduced impact on haemostasis and coagulation (therefore better option in VTE/liver abnormalities)
+ more physiological (oestradiol released into circulation), logistically difficult to coadminister progesterone in unhysterectomised patients

23
Q

Side effects related to oestrogen

A
fluid retention
Nausea
Headaches
Breast enlargement
Leg cramps
Dyspepsia

Tend to settle within a few weeks

24
Q

Progesterone addition in HRT

A

added for 10 days per calendar month (mimic menstrual cycle)
Cyclical regimen for perimenopauseal women
Continuous for post-menopausal women (no bleeding)

25
Q

Side effects related to progestogens

A
Fluid retention
Breast tenderness
Headaches
Acne
Mood swings
Depression
Irritability
Bloating
Constipation
Increased appetite

usually more trouble-some than oestrogen related side effects, especially in first few months
Switching dose or type of progestogen or to Mirena IUD may help

26
Q

Symptoms of testosterone deficiency in a female

A

Loss of libido
Decreased sexual activity
Fatigue
Reduced feeling of physical well-being

27
Q

Breast cancer risk with HRT

A

increases risk by 4 in 1000 (usually 15/1000)
No increase in risk if used for less than 5 years
more associated with progesterone than oestrogen

28
Q

Endometrial cancer risk with HRT

A

only in unopposed oestrogen if woman still has uterus

Therefore always use progesterone unless no uterus

29
Q

VTE risk with HRT

A

Increases risk 2- fold (overall impact small given that background risk is low)
- significantly increased risk in smokers, obese, underlying thrombophilia or history of VTE
Highest risk in first year of use

30
Q

Absolute contraindications to HRT

A
Suspected pregnancy
Breast cancer
Endometrial cancer
Active liver disease
Uncontrolled HTN
Known VTE
Known thrombophilia
Otosclerosis
31
Q

relative contraindications to HRT

A
Uninvestigated abnormal bleeding
Large uterine fibroids
Past history of benign breast disease
Unconfirmed personal history or strong family history of VTE
Chronic stable liver disease
Migraine with aura
32
Q

Benefits of HRT

A

Most effective therapy for perimenopausal symptoms (vasomotor, urogenital, sexual function)
Treatment of osteoporosis
Reduced risk of ?CVD, colon cancer

33
Q

Vaginal oestrogen

A

safe for those contraindicated for systemic HRT
useful only for urogenital symptoms
progesterone not required
daily for 2 weeks, then 1-2 times weekly for 12 months

34
Q

Expected time for HRT to improve hot flush symptoms

A

4-6 weeks of treatment

35
Q

Production of testosterone in women and effect of menopause

A

50% occurs in ovaries
other 50% in adrenals and adipose
Production not generally affected by natural menopause, but may become deficient if chemoradiation or surgical induced menopause

36
Q

Regimens of HRT

A

Oestrogen only - post-hysterectomy
Cyclical progesterone + oestrogen - perimenopausal women (still will have period)
Continuous progesterone + oestrogen - postmenopausal women (will not have bleeding)